# Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo

> **NCT06162611** · PHASE4 · RECRUITING · sponsor: **Lori Gawron** · enrollment: 790 (estimated)

## Conditions studied

- Emergency Contraception

## Interventions

- **DRUG:** Etonogestrel implant with Oral Levonorgestrel emergency contraception 1.5mg
- **DEVICE:** Etonogestrel implant with oral placebo

## Key facts

- **NCT ID:** NCT06162611
- **Lead sponsor:** Lori Gawron
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-06
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-05-31
- **Target enrollment:** 790 (ESTIMATED)
- **Last updated:** 2025-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06162611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06162611, "Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06162611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*